5,5'-Dibutyl-2,2'-dimethoxy-biphenyl | 1376641-82-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5,5'-Dibutyl-2,2'-dimethoxy-biphenyl
• 英文别名: 4-butyl-2-(5-butyl-2-methoxyphenyl)-1-methoxybenzene
• CAS: 1376641-82-5
• 化学式: C₂₂H₃₀O₂
• 分子量: 326.479
• InChiKey: OPYQBMOQZKRXBS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.3
• 重原子数：
  24
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5,5'-Dibutyl-2,2'-dimethoxy-biphenyl 在 aluminum (III) chloride 、 二甲基硫 、 溴 、 三乙胺 作用下， 以 甲苯 为溶剂， 反应 1.0h， 生成 3-bromo-5,5'-dibutyl-2,2'-biphenyldiol 、 5,5'-dibutyl-3,3'-dibromo-2,2'-biphenyldiol
  参考文献：
  名称：

  Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds

  摘要：

  A series of novel magnolol derivatives were synthesised and evaluated for in vitro antimicrobial and antiproliferative activities. We found that most of the compounds were effective inhibitors of Staphylococcus aureus, MRSA and VRE with MIC in the range of 1-64 mu g/mL and MBC in the range of 1-128 mu g/mL. Few derivatives also exhibited promising antifungal activity. Some magnolol analogues exhibited promising antiproliferative activity than parent magnolol when tested against three human cancer cell lines. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.12.039
• 作为产物：
  描述：

  2-bromo-4-n-butylanisole 在 四(三苯基膦)钯 、 正丁基锂 、 sodium carbonate 作用下， 以 四氢呋喃 、 乙二醇二甲醚 为溶剂， 反应 8.0h， 生成 5,5'-Dibutyl-2,2'-dimethoxy-biphenyl
  参考文献：
  名称：

  Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds

  摘要：

  A series of novel magnolol derivatives were synthesised and evaluated for in vitro antimicrobial and antiproliferative activities. We found that most of the compounds were effective inhibitors of Staphylococcus aureus, MRSA and VRE with MIC in the range of 1-64 mu g/mL and MBC in the range of 1-128 mu g/mL. Few derivatives also exhibited promising antifungal activity. Some magnolol analogues exhibited promising antiproliferative activity than parent magnolol when tested against three human cancer cell lines. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.12.039